GHRS
GH Research PLCNASDAQHealthcare$14.57-1.02%ClosedMarket Cap: $903.8M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
3.36
P/S
0.00
EV/EBITDA
-13.75
DCF Value
$4.05
FCF Yield
-4.7%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-16.3%
ROA
-16.7%
ROIC
-21.7%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $0.00 | -Infinity% | $-16.7M | $-14.1M | $-0.23 | — |
| FY 2025 | $0.00 | -Infinity% | $-60.7M | $-48.3M | $-0.79 | — |
| Q3 2025 | $0.00 | -Infinity% | $-16.5M | $-14.0M | $-0.23 | — |
| Q2 2025 | $0.00 | NaN% | $-14.7M | $-9.3M | $-0.15 | — |
| Q1 2025 | $0.00 | NaN% | $-12.7M | $-10.8M | $-0.19 | — |
| Q4 2024 | $0.00 | NaN% | $-12.9M | $-8.8M | $-0.17 | — |
| FY 2024 | $0.00 | NaN% | $-50.3M | $-39.0M | $-0.75 | — |
| Q3 2024 | $0.00 | NaN% | $-12.6M | $-12.1M | $-0.23 | — |
| Q2 2024 | $0.00 | NaN% | $-13.2M | $-10.4M | $-0.20 | — |
| Q1 2024 | $0.00 | NaN% | $-11.5M | $-7.7M | $-0.15 | — |
| Q4 2023 | $0.00 | NaN% | $-11.2M | $-11.3M | $-0.22 | — |
| FY 2023 | $0.00 | NaN% | $-41.2M | $-35.6M | $-0.68 | — |